Semaglutide works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake, making it a powerful appetite suppressant
Monitor closely for serious risks, including: Diabetic ketoacidosis (symptoms: persistent nausea, vomiting, fatigue, even with normal blood sugar), Acute pancreatitis (intense abdominal pain), Thyroid C-cell tumors (family history warning), Gallbladder issues (pain after meals)
There are many reasons you might consider stopping GLP-1 therapy
Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary
Published body composition data suggests Mazdutides dual mechanism may provide better balance between fat loss and muscle preservation than Retatrutides triple approach